Top Tweets for #selution
We have just finished live transmission from Yeditepe University hospital cath labs. to #JIMGISE2026 meeting treating patient with only DCB of LAD, D and OM. This is important collaboration with JIMGISE and #TSC. Looking forward for more activities. #DCB #cardiology #selution
With the great results of #SELUTION4ISR & #SELUTION DeNovo trials at #TCT2025, the "lowly balloon" is being reborn for PCI. Since I'm always thinking about #AngioHistory, I thought this clip from my 1985 (i.e. pre-stent) interview w Andreas Gruentzig would be appropriate today.
Results from #SELUTION are encouraging, but some aspects deserve attention: 👇
1️⃣ Observed TVF rate of 4.4% (DES) was lower than expected (assumed rate 6%)
2️⃣ 50% non-inferiority margin is somewhat large. With a more conservative approach, including a 33% margin, non-inferiority wouldn’t hold (Upper CI 2.38% higher than 1.60%)
3️⃣ Periprocedural MI ≈1%: very low, raising possible underreporting.
Overall, this is a technology with a great potential, but let’s safeguard it through trial evaluation and critical scrutiny, not overstatement. We should embrace innovation with hope and thoughtful assessment, not hype.
@mmamas1973 @evandrofilhobr @djc795 @Costa_F_8 @DFCapodanno @mirvatalasnag @drjohnm @HadyLichaaMD @DLBHATTMD @SVRaoMD @Hragy @dukwoo_park @pash22 @Ortega_Paz @EricSecemskyMD @BURZOTTA_F @drptca @kaulcsmc @kevinjamescroce @GGStefanini
SELUTION DeNovo - non inferiority for TVF at 1 yr demonstrated. Randomisation before lesion prep
➡️ 20% DES use in DEB arm
➡️ 50% non inferiority margin of overall tvf in both arms !!!!!
➡️ TVF 4.4 vs 5.3% in des and deb arms
This is a landmark moment- analogous to introduction of DES (even with generous non inferiority margin) #TCT2025 @crfheart
Wild clapping in audience @Hragy @jgranadacrf @mirvatalasnag @drptca @SrihariNaiduMD @realarainmd @DrAsifQasim @DavidWienerMD @sbrugaletta @alaide_chief
Finally! #Sirolimus-eluting balloon (#Selution) demonstrates non-inferiority to DES in de novo coronary lesions! Game-changing implications for coronary intervention! #PCI #TCT2025 #LeaveNothingBehind #DCB #DEB #SelutionDeNovo #CardioTwitter #InterventionalCardiology
SELUTION DeNovo 🇪🇺 | #TCT2025
Large, pragmatic strategy trial: sirolimus DCB-first vs contemporary DES for de novo lesions.
Unique strategy: patients randomized before lesion preparation — unlike prior DCB studies.
✅ Non-inferior for 1-year TVF (5.3% vs 4.4%)
💀 Death, MI, thrombosis all similar
🧠 80% of DCB patients avoided a stent
⚠️ Slightly higher TVR (3.3% vs 2.1%)
🔍 Low intravascular imaging use (~16%) outcomes could be even stronger with optimized prep & imaging guidance.
A real step toward “leave nothing behind.”
#DCB #InterventionalCardiology #TCT2025
With the great results of #SELUTION4ISR & #SELUTION DeNovo trials at #TCT2025, the "lowly balloon" is being reborn for PCI. Since I'm always thinking about #AngioHistory, I thought this clip from my 1985 (i.e. pre-stent) interview w Andreas Gruentzig would be appropriate today.
@mmamas1973 We don’t want to leave metal behind however the early POBA experience was marred by abrupt vessel closure..back to that practice requires evidence #SELUTION De Novo is certainly an important step in that direction
@CERC_CRO is proud to partner with @cordis for another game changing trial #Selution study which showed that lesion préparation was systematic and bail out decreased with increasing site experience with the device
#CardioTwitter #Cardiology #europcr2024
@PCRonline
This is looking like it’s going to be great discussion @LINCmeeting on the 7th of June. Join us Online or in person. @MedallianceSA #selution #CLI #BTK #SirolimusDEB #GlobalExperts
We are so honored to have been selected as a finalist for the Supes' Choice Awards in the category "SEL Solution of the Year"! Created by @IEI_K12, Supes' Choice is the only education industry awards judged exclusively by school district superintendents.
#SELution #supeschoice
#MTF, #UMB und #Selution: Das sind die Gewinner der diesjährigen #Partnerawards von Sophos. Alle drei erhielten zudem noch ein Geschenk; eines der Unternehmen durfte sich gleich dreifach freuen. @umb1978 @Sophos #Cybersecurity https://t.co/XAHJJi5tK8
📍 Wir sind dabei am @Cisco Cisco Live Event in Barcelona!
Wir freuen uns auf spannende Keynotes und innovative Lösungen.
#cisco #ciscolive #ciscoliveeurope #barcelona #selution #staytuned @Cisco_CH @CiscoLiveEurope
Also Swiss drug-coated balloon maker MedAlliance got $22m equity financing from Shenzhen Salubris Pharma to advance #Selution DCB with sirolimus-delivering micro-reservoir in coating #medtech #cardiology #vascular
Last Seen Hashtags on Sotwe
angiekhoury
ทอมนัดเย็ด
Seen from Thailand
paremmantyöelämänvoimavarat
Seen from United States
가터
Seen from Korea
f40pro
Seen from United States
taksimgay
Seen from Turkey
MyAlpinoHealth
Seen from United States
minichat anxiouspanda
Seen from Netherlands
minichat()
Seen from Mexico
pawgsvsbbc
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.3M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.3M followers
Bill Gates
@billgates
65.1M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers